Replimune Group Management

Management Kriterienprüfungen 3/4

Replimune Group's CEO ist Sush Patel , ernannt in Apr 2024, hat eine Amtszeit von weniger als einem Jahr. Die jährliche Gesamtvergütung beträgt $2.60M , bestehend aus 17.2% Gehalt und 82.8% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.082% der Aktien des Unternehmens, im Wert von $384.66K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 0.5 Jahre bzw. 6.1 Jahre.

Wichtige Informationen

Sush Patel

Geschäftsführender

US$2.6m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts17.2%
Amtszeit als Geschäftsführerless than a year
Eigentum des Geschäftsführers0.07%
Durchschnittliche Amtszeit des Managementsless than a year
Durchschnittliche Amtszeit der Vorstandsmitglieder6.3yrs

Jüngste Management Updates

Recent updates

Replimune: Strong Data In A Highly Differentiated Space

Sep 03

Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?

Aug 16
Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?

Replimune: Continuing To Justify The Bear Thesis (For Now)

May 22

Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Feb 06
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer

Jan 23

Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)

Dec 25
Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)

Is Replimune Group (NASDAQ:REPL) A Risky Investment?

Jul 13
Is Replimune Group (NASDAQ:REPL) A Risky Investment?

Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?

Apr 05
Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?

A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Jan 06
A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Replimune secures $200M term loan

Oct 07

Replimune: Recent Developments Strengthen Bull Thesis

Aug 12

Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Aug 06
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Replimune Group GAAP EPS of -$0.78 misses by $0.15

Aug 04

Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate

Jun 24
Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate

We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate

Apr 04
We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate

Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth

Dec 16
Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth

Replimune: In The 'Buy Zone' Again

Oct 01

Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Sep 02
Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business

May 24
Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business

Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic

Apr 30

We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow

Feb 08
We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow

Replimune Group EPS misses by $0.03

Feb 04

Dosing underway in Replimune's early-stage cancer study with gene therapy

Jan 05

Replimune: Interesting Developer Of Oncolytic Immunotherapies

Dec 06

Replimune Group EPS misses by $0.02

Nov 05

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Sush Patel im Vergleich zu den Einnahmen von Replimune Group verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

-US$220m

Mar 31 2024n/an/a

-US$216m

Dec 31 2023n/an/a

-US$210m

Sep 30 2023n/an/a

-US$199m

Jun 30 2023n/an/a

-US$182m

Mar 31 2023US$3mUS$447k

-US$174m

Dec 31 2022n/an/a

-US$157m

Sep 30 2022n/an/a

-US$147m

Jun 30 2022n/an/a

-US$133m

Mar 31 2022US$7mUS$394k

-US$118m

Vergütung im Vergleich zum Markt: SushDie Gesamtvergütung ($USD2.60M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD2.44M).

Entschädigung vs. Einkommen: SushDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Sush Patel (53 yo)

less than a year

Amtszeit

US$2,595,003

Vergütung

Dr. Sushil Patel, also known as Sush,Ph D, is CEO & Director of Replimune Group, Inc. from April 1, 2024. Dr. Patel served as the Chief Commercial Officer at Replimune Group, Inc. since May 3, 2021 and ser...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Philip Astley-Sparke
Executive Chairman9.7yrsUS$6.02m1.87%
$ 13.9m
Emily Hill
Chief Financial Officerless than a yearUS$3.61m0.017%
$ 129.8k
Konstantinos Xynos
Chief Medical Officer1.8yrsUS$2.45m0.017%
$ 123.7k
Sushil Patel
CEO & Directorless than a yearUS$2.60m0.074%
$ 549.3k
Robert Coffin
Founderno dataUS$5.72m2.57%
$ 19.2m
Andrew Schwendenman
Chief Accounting Officer & Treasurer1.3yrskeine Daten0.010%
$ 76.6k
Christopher Sarchi
Chief Commercial Officer1.8yrskeine Daten0.017%
$ 129.8k
Paul Bullock
Chief Manufacturing Officer & Framingham Site Headless than a yearkeine Datenkeine Daten

1.0yrs

Durchschnittliche Betriebszugehörigkeit

53yo

Durchschnittliches Alter

Erfahrenes Management: REPLDas Führungsteam des Unternehmens gilt nicht als erfahren ( 0.5 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Philip Astley-Sparke
Executive Chairman9.7yrsUS$6.02m1.87%
$ 13.9m
Sushil Patel
CEO & Directorless than a yearUS$2.60m0.074%
$ 549.3k
Robert Coffin
Founder9.7yrsUS$5.72m2.57%
$ 19.2m
Joseph Slattery
Independent Director6.9yrsUS$362.60k0.0098%
$ 72.7k
Hyam Levitsky
Independent Non-Executive Director6.3yrsUS$355.10k0%
$ 0
Paolo Pucci
Independent Director4.4yrsUS$360.10k0%
$ 0
Madhavan Balachandran
Directorno datakeine Datenkeine Daten
Kapil Dhingra
Independent Director7.2yrsUS$357.60k0%
$ 0
Christy Oliger
Independent Director2.8yrsUS$352.60k0%
$ 0
Dieter Weinand
Lead Independent Director6.3yrsUS$516.81k0%
$ 0
Veleka Peeples-Dyer
Independent Director1.3yrsUS$667.97k0%
$ 0

6.3yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrener Vorstand: REPLDie Vorstandsmitglieder gelten als erfahren (6.1 Jahre durchschnittliche Amtszeit).